(HP-12) ICR 2015 Photos & Presentations

(HP-12) ICR 2015 Photos & Presentations


Pictures from the 13th Annual Ion Channel Retreat


Presentations from the 13th Annual Ion Channel Retreat


Energetics of cAMP binding to HCN channels – Eric Accili, PhD

Ion channels: novel biomarkers and therapeutic targets in cancer – Annarosa Arcangeli

Dalazatide, first-in-class Kv1.3 channel blocker, an immunomodulators journey from sea to clinic – Shawn Iadonato

SB Ion Channels: A division of SB Drug Discovery

Molecular Characterization of the Na+/H+ Exchanger in Human Disease – Dr. Larry Fliegel

Role of ANO1 (TMEM16A) channels in inflammatory pain – Nikita Gamper

(–)-Englerin A as a novel potent activator of TRPC4 and TRPC5 channels – Hannah J. Gaunt

Targeting voltage-gated K+ channels in cancer reveal new biochemical pathways and therapeutic opportunities – Saverio Gentile, Ph.D.

Identification and characterization of novel NMDA receptor positive allosteric modulators (PAMs) – David H Hackos

Modulation of TRP channels by resolvins in mouse and human – Ru-Rong Ji, PhD

Development of Screening Tools to Identify Nicotinic Subtype-Selective Compounds – Glenn Kirsch, PhD

Scn10a promoter studies: Utilizing an Scn10a-EGFP reporter mouse to study changes in NaV1.8 expression in peripheral sensory neurons and novel NaV1.8 expression in the central nervous system – Van B. Lu, PhD

Complementary HTS Technologies towards a more Rigorous Safety Screening Paradigm – George Okeyo, Ph.D.

Integrated microfluidic device for drug accumulation measurement on a single MDR transporter-expressing prostate cancer cell isolated among blood cells – Paul Li

Metformin- an old drug but with new targets that affect endothelial function: eNOS, transporters, cancer and ageing. A drug for all reasons? – Professor Chris Triggle

ICAGEN: Advancing Ion Channel & Transporter Discovery – Douglas Krafte, CSO